MYC is a strong transcriptional activator of eIF4E (Jones et al., 1996), and thus, by targeting this eIF4E‐MYC feed‐forward loop (Fig. 6E), metformin could achieve cell cycle arrest and growth inhibition of CRC cells (Lin et al., 2009). Here, MYC is linked to colorectal carcinoma.